2013
DOI: 10.1016/j.thromres.2013.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Coagulation Factors and Recurrence of Ischemic and Bleeding Adverse Events in Patients with Acute Coronary Syndromes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
26
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 59 publications
1
26
0
Order By: Relevance
“…New anticoagulant drugs, which show less side effects and a better tolerability, recently are used widely. Therefore, their selected use in patients with increased levels of coagulation factors, including FVII, may not only improve the clinical outcome after MI but also prevent the onset of MI …”
Section: Introductionmentioning
confidence: 99%
“…New anticoagulant drugs, which show less side effects and a better tolerability, recently are used widely. Therefore, their selected use in patients with increased levels of coagulation factors, including FVII, may not only improve the clinical outcome after MI but also prevent the onset of MI …”
Section: Introductionmentioning
confidence: 99%
“…Increased fibrinogen plasmatic levels are directly related with the risk of ACS [8]. It takes part in the atherosclerosis process inducing plaque growth, stimulating adhesion of platelets and white blood cells to the vessels wall cells, endothelial dysfunction, and promoting muscle cell proliferation and migration [9,10]. Plasma fibrinogen levels have been found to be higher in patients with ACS compared to those of patients with stable coronary artery disease or healthy controls, and higher plasma fibrinogen levels may be predictors of poor long-term prognosis [11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…In fish, the complement system appears to be fully equipped with the three C3-activation pathways and the cytolytic pathway, showing many of the typical effector activities, such as target cell killing, opsonization, and anaphylatoxic leukocyte stimulation (Nakao et al, 2011). FI to FXIII play important roles in tissue coagulation, fibrinolysis, and anticoagulation (Campo et al, 2013;Hoppe, 2014). C5 is a key factor linking the complement system and coagulation cascade (Ehrnthaller et al, 2011;Kolev et al, 2014).…”
Section: Discussionmentioning
confidence: 99%